Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Rivera Jose E
EVP, General Counsel at Intellia Therapeutics. Filing since 26 May 2020.
CIK 0001671870
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
1 Apr 2021
EVP, General Counsel
Sold, plan not stated
50,455
$4.16M
27.8%
NTLA
Intellia Therapeutics, Inc.
9 Feb 2021
EVP, General Counsel
Sold, plan not stated
11,489
$861.68K
8.9%
NTLA
Intellia Therapeutics, Inc.
1 Feb 2021
EVP, General Counsel
Sold, plan not stated
54,659
$3.50M
38.1%
NTLA
Intellia Therapeutics, Inc.
5 Jan 2021
EVP, General Counsel
Sold, plan not stated
2,078
$116.08K
3.8%
NTLA
Intellia Therapeutics, Inc.
1 Dec 2020
EVP, General Counsel
Sold, plan not stated
3,364
$128.53K
6.5%
NTLA
Intellia Therapeutics, Inc.
18 Nov 2020
EVP, General Counsel
Sold, plan not stated
624
$21.84K
1.3%
NTLA
Intellia Therapeutics, Inc.
16 Nov 2020
EVP, General Counsel
Sold, plan not stated
6,029
$206.73K
11.4%
NTLA
Intellia Therapeutics, Inc.
4 Nov 2020
EVP, General Counsel
Sold, plan not stated
3,364
$94.19K
7.4%
NTLA
Intellia Therapeutics, Inc.
15 Oct 2020
EVP, General Counsel
Sold, plan not stated
5,615
$135.88K
12.1%
NTLA
Intellia Therapeutics, Inc.
15 Sep 2020
EVP, General Counsel
Sold, plan not stated
5,615
$118.14K
13.4%
NTLA
Intellia Therapeutics, Inc.
18 Aug 2020
EVP, General Counsel
Sold, plan not stated
5,615
$117.92K
15.0%
NTLA
Intellia Therapeutics, Inc.
15 Jul 2020
EVP, General Counsel
Sold, plan not stated
5,615
$127.46K
16.9%
NTLA
Intellia Therapeutics, Inc.
16 Jun 2020
EVP, General Counsel
Sold, plan not stated
5,615
$117.92K
20.1%
NTLA
Intellia Therapeutics, Inc.
26 May 2020
EVP, General Counsel
Sold, plan not stated
5,615
$119.09K
2.0%
14 decisions on file.
